# Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease

> **NCT00521742** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 300 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Glyburide
- **DRUG:** Pioglitazone
- **DRUG:** Glyburide

## Key facts

- **NCT ID:** NCT00521742
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-03
- **Primary completion:** 2003-01
- **Final completion:** 2003-01
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2012-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00521742

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00521742, "Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00521742. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*